Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma

ClinicalTrials.gov ID: NCT02455245

Public ClinicalTrials.gov record NCT02455245. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 6:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is trying to learn and understand if the chemotherapy drug called carboplatin works as well as the standard therapy. The standard therapy for Low Grade Glioma (LGG) in children and young adults is using a combination of carboplatin and vincristine. Studies in children have shown that the use of carboplatin alone has promise of being just as effective for treating LGG as standard therapy. Additionally, this study will try to understand if treatment with carboplatin alone is associated with an improved quality of life for LGG patients and their families.

Study identification

NCT ID
NCT02455245
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alicia Lenzen
Other
Enrollment
95 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2015 (Actual)
Primary completion
Aug 31, 2025 (Actual)
Completion
Nov 30, 2025 (Actual)
Last update posted
Sep 2, 2026

2015 – 2025

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Phoenix Children's Hospital Phoeniz Arizona 85016 —
Rady Children's Hospital San Diego California 92123 —
Yale University New Haven Connecticut 06520 —
Orlando Health, Inc. Orlando Florida 32806 —
Ann & Robert H. Lurie Children's Hosptial of Chicago Chicago Illinois 60611 —
St. Vincent Peyton Manning Children's Hospital Indianapolis Indiana 46260 —
University of Iowa Iowa City Iowa 52242 —
The Johns Hopkins Hospital Baltimore Maryland 21287 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
University of Michigan, C.S. Mott Children's Hospital Ann Arbor Michigan 48109-5652 —
Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis Minnesota 55404 —
Saint Louis University at SSM Cardinal Glennon Children's Medical Center St Louis Missouri 63103-2006 —
Washington University School of Medicine St Louis Missouri 63110-1010 —
Albany Medical Center Albany New York 12208-3479 —
Duke University Medical School Durham North Carolina 27705-4682 —
Children's Hospital Medical Center of Akron Akron Ohio 44308-1062 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Dayton Children's Hospital Dayton Ohio 45404-1815 —
American Family Children's Hospital Madison Wisconsin 53792 —
Medical College of Wiscosin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02455245, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2026 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02455245 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →